| 1 |
Kim TW, Kim WK, Lee JH, Kim SB, Kim SW, Suh C, et al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis. J Korean Med Sci 1998;13:587-90.
|
| 2 |
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
|
| 3 |
Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak-Gottl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999;19:2568-72.
DOI
ScienceOn
|
| 4 |
Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:887S-968S.
DOI
|
| 5 |
Bucciarelli P, Rosendaal FR, Tripodi A, Mannucci PM, De Stefano V, Palareti G, et al. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol 1999;19:1026-33.
DOI
ScienceOn
|
| 6 |
Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med 2007;131:872-84.
|
| 7 |
Rook JL, Nugent DJ, Young G. Pediatric stroke and methylenetetrahydrofolate reductase polymorphisms: an examination of C677T and A1298C mutations. J Pediatr Hematol Oncol 2005; 27:590-3.
DOI
ScienceOn
|
| 8 |
Nowak-Gottl U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678-82.
|
| 9 |
Nowak-Gottl U, Junker R, Hartmeier M, Koch HG, Munchow N, Assmann G, et al. Increased lipoprotein (a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100:743-8.
DOI
ScienceOn
|
| 10 |
Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 2003;1:915-21.
DOI
ScienceOn
|
| 11 |
Boffa MC, Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007;16:634-41.
DOI
|
| 12 |
Manco-Johnson MJ, Grabowski EF, Hellgreen M, Kemahli AS, Massicotte MP, Muntean W, et al. Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost 2002;88:155-6.
|
| 13 |
Nowak-Gottl U, Duering C, Kempf-Bielack B, Strater R. Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb 2003;33: 269-74.
DOI
|
| 14 |
Turebylu R, Salis R, Erbe R, Martin D, Lakshminrusimha S, Ryan RM. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. J Perinatol 2007; 27:490-5.
DOI
ScienceOn
|
| 15 |
Schmidt B, Zipursky A. Thrombotic disease in newborn infants. Clin Perinatol 1984;11:461-88.
|
| 16 |
Khilnani P, Goldstein B, Todres ID. Double lumen umbilical venous catheters in critically ill neonates: a randomized prospective study. Crit Care Med 1991;19:1348-51.
DOI
ScienceOn
|
| 17 |
Tanke RB, van Megen R, Daniëls O. Thrombus detection on central venous catheters in the neonatal intensive care unit. Angiology 1994;45:477-80.
DOI
ScienceOn
|
| 18 |
O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 2002;110:e51.
DOI
ScienceOn
|
| 19 |
Butler-O'Hara M, Buzzard CJ, Reubens L, McDermott MP, DiGrazio W, D'Angio CT. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics 2006; 118:e25-35.
DOI
ScienceOn
|
| 20 |
Narang S, Roy J, Stevens TP, Butler-O'Hara M, Mullen CA, D'Angio CT. Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants. Pediatr Blood Cancer 2009;52:75-9.
DOI
ScienceOn
|
| 21 |
Greenway A, Massicotte MP, Monagle P. Neonatal thrombosis and its treatment. Blood Rev 2004;18:75-84.
DOI
ScienceOn
|
| 22 |
Barnes C, Newall F, Monagle P. Post-thrombotic syndrome. Arch Dis Child 2002;86:212-4.
DOI
ScienceOn
|
| 23 |
Barrington KJ. Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Syst Rev 2000;(2): CD000505.
|
| 24 |
Barrington KJ. Umbilical artery catheters in the newborn: effects of catheter design (end vs side hole). Cochrane Database Syst Rev 2000;(2):CD000508.
|
| 25 |
Barrington KJ. Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database Syst Rev 2000;(2):CD000507.
|
| 26 |
Lau KK, Stoffman JM, Williams S, McCusker P, Brandao L, Patel S, et al. Neonatal renal vein thrombosis: review of the English-language literature between 1992 and 2006. Pediatrics 2007;120:e1278-84.
DOI
|
| 27 |
Kosch A, Kuwertz-Broking E, Heller C, Kurnik K, Schobess R, Nowak-Gottl U. Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood 2004; 104:1356-60.
DOI
ScienceOn
|
| 28 |
Marks SD, Massicotte MP, Steele BT, Matsell DG, Filler G, Shah PS, et al. Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. J Pediatr 2005;146:811-6.
DOI
ScienceOn
|
| 29 |
Winyard PJ, Bharucha T, De Bruyn R, Dillon MJ, van't Hoff W, Trompeter RS, et al. Perinatal renal venous thrombosis: presenting renal length predicts outcome. Arch Dis Child Fetal Neonatal Ed. 2006;91:F273-8.
DOI
|
| 30 |
Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001;219:645- 50.
|
| 31 |
Morag I, Epelman M, Daneman A, Moineddin R, Parvez B, Shechter T, et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr 2006;148:735-9.
DOI
ScienceOn
|
| 32 |
Yadav S, Dutta AK, Sarin SK. Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr 1993;17:392-6.
DOI
ScienceOn
|
| 33 |
Ramenghi LA, Govaert P, Fumagalli M, Bassi L, Mosca F. Neonatal cerebral sinovenous thrombosis. Semin Fetal Neonatal Med 2009;14:278-83.
DOI
ScienceOn
|
| 34 |
Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odievre M, Alagille D. Portal obstruction in children. I. Cinical investigation and hemorrhage risk. J Pediatr 1983;103:696-702.
DOI
|
| 35 |
deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417-23.
DOI
ScienceOn
|
| 36 |
Wasay M, Dai AI, Ansari M, Shaikh Z, Roach ES. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol 2008;23:26-31.
|
| 37 |
Wu YW, Hamrick SE, Miller SP, Haward MF, Lai MC, Callen PW, et al. Intraventricular hemorrhage in term neonates caused by sinovenous thrombosis. Ann Neurol 2003;54:123-6.
DOI
ScienceOn
|
| 38 |
Fitzgerald KC, Williams LS, Garg BP, Carvalho KS, Golomb MR. Cerebral sinovenous thrombosis in the neonate. Arch Neurol 2006;63:405-9.
DOI
ScienceOn
|
| 39 |
Berfelo FJ, Kersbergen KJ, van Ommen CH, Govaert P, van Straaten HL, Poll-The BT, et al. Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke 2010;41:1382-8.
DOI
ScienceOn
|
| 40 |
Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;96:939-43.
|
| 41 |
Andrew M. Developmental hemostasis: relevance to hemostatic problems during childhood. Semin Thromb Hemost 1995;21:341- 56.
DOI
|
| 42 |
van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001;139: 676-81.
DOI
ScienceOn
|
| 43 |
Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009;33: 52-65.
DOI
ScienceOn
|
| 44 |
Saxonhouse MA, Burchfield DJ. The evaluation and management of postnatal thromboses. J Perinatol 2009;29:467-78.
DOI
ScienceOn
|
| 45 |
Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-7.
DOI
ScienceOn
|
| 46 |
Thornburg C, Pipe S. Neonatal thromboembolic emergencies. Semin Fetal Neonatal Med 2006;11:198-206.
DOI
ScienceOn
|
| 47 |
Manco-Johnson MJ. Development of hemostasis in the fetus. Thromb Res 2005;115 (suppl 1):55-63.
|
| 48 |
Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health 1999;35:460-5.
DOI
ScienceOn
|
| 49 |
Saracco P, Parodi E, Fabris C, Cecinati V, Molinari AC, Giordano P. Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors. Thromb Res 2009;123:805-9.
DOI
ScienceOn
|
| 50 |
Nowak-Gottl U, Junker R, Kreuz W, von Eckardstein A, Kosch A, Nohe N, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001;97:858-62.
DOI
ScienceOn
|
| 51 |
Nowak-Gottl U, Dubbers A, Kececioglu D, Koch HG, Kotthoff S, Runde J, et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997;131:608-12.
DOI
ScienceOn
|
| 52 |
Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503-6.
DOI
ScienceOn
|
| 53 |
Dahlback B, Hillarp A, Rosen S, Zoller B. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis. Ann Hematol 1996;72:166-76.
DOI
ScienceOn
|
| 54 |
Zoller B, Hillarp A, Berntorp E, Dahlback B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annu Rev Med 1997;48:45-58.
DOI
ScienceOn
|
| 55 |
Schneppenheim R, Greiner J. Thrombosis in infants and children. Hematology Am Soc Hematol Educ Program 2006:86-96.
|
webmaster
